[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @EisaiGlobalOnc Eisai Oncology Medical Eisai Oncology Medical posts on X about $4523t, japan, amsterdam, drugs the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1397558872404017152/interactions)  - X Week XXXXXX +11% - X Month XXXXXXX +453% - X Months XXXXXXX +53% - X Year XXXXXXX -XX% ### Mentions: XX [#](/creator/twitter::1397558872404017152/posts_active)  - X Month XX -XX% - X Months XX +1,000% - X Year XX +740% ### Followers: XXXXX [#](/creator/twitter::1397558872404017152/followers)  - X Week XXXXX +1.10% - X Month XXXXX +2.10% - X Months XXXXX +8.50% - X Year XXXXX +19% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1397558872404017152/influencer_rank)  ### Social Influence [#](/creator/twitter::1397558872404017152/influence) --- **Social category influence** [countries](/list/countries) XX% [travel destinations](/list/travel-destinations) XXXX% **Social topic influence** [$4523t](/topic/$4523t) 100%, [japan](/topic/japan) 12.5%, [amsterdam](/topic/amsterdam) 6.25%, [drugs](/topic/drugs) 6.25%, [switzerland](/topic/switzerland) 6.25%, [australia](/topic/australia) 6.25%, [sydney](/topic/sydney) 6.25%, [new zealand](/topic/new-zealand) 6.25%, [dtc](/topic/dtc) XXXX% **Top accounts mentioned or mentioned by** [@jgong15](/creator/undefined) [@maychomd](/creator/undefined) [@icmlugano](/creator/undefined) ### Top Social Posts [#](/creator/twitter::1397558872404017152/posts) --- Top posts by engagements in the last XX hours "Theres been debate that patients with hepatitis B virus and cirrhosis may have a chance for early detection of hepatocellular carcinoma (HCC). Hear doctors @jgong15 and @MayCho_MD discuss the possible link between hepatitis and #livercancer"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1937545016181670361) 2025-06-24 16:15:04 UTC 1254 followers, 36.9K engagements "Join us from July 17-19 at the joint 67th Annual Meeting of the Japan Society of Gynecologic Oncology and Asian Society of Gynecologic Oncology 2025 congress. Well be there sharing the latest research in endometrial cancer. #ASGO2025 #JSGO2025"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1945460910212223141) 2025-07-16 12:30:00 UTC 1254 followers, XXX engagements "Deregulation of complex signaling pathways may contribute to cancer which has led to research and studies of targeted cancer therapies"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1938269795876544586) 2025-06-26 16:15:05 UTC 1254 followers, XXX engagements "Our team recently attended the Annual Meeting of the Japanese Association of Supportive Care in Cancer. We were honored to meet with many attendees and to share research. #JASCC2025 #gynsm"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1945090972708188387) 2025-07-15 12:00:00 UTC 1254 followers, XX engagements "What factors guide treatment decisions for unresectable non-metastatic hepatocellular carcinoma (HCC) Krittiya Korphaisarn MD explains more"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1944728587221061866) 2025-07-14 12:00:01 UTC 1254 followers, 1067 engagements "Join us from July 17-19 at the joint 67th Annual Meeting of the Japan Society of Gynecologic Oncology and Asian Society of Gynecologic Oncology 2025 congress. Well be there sharing the latest research in endometrial cancer. #ASGO2025 #JSGO2025"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1946389532405883133) 2025-07-19 02:00:01 UTC 1255 followers, XXX engagements "Our team shared new research at the International Kidney Cancer Symposium in Amsterdam. #oncology #IKCSEU25 #kcsm"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1947265309485711823) 2025-07-21 12:00:02 UTC 1255 followers, XX engagements "The potential use of monoclonal antibodies (mAbs) to precisely target tumors changed the shape of #cancerresearch in the mid-1970s. In 2000 antibody-drug conjugates (ADCs) built from that strength and added to a new approach in cancer treatment. #cancertechnology"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1945815760322109851) 2025-07-17 12:00:03 UTC 1254 followers, XX engagements "Enrollment is now open for our randomized dose optimization study of E7386 in combination with other anticancer drug(s) in patients with endometrial carcinoma. #oncology #EC"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1943320124968349841) 2025-07-10 14:43:17 UTC 1254 followers, XXX engagements "We were proud to have been able to share new research on follicular lymphoma at the 18th International Conference on Malignant Lymphoma (@ICMLugano) in Lugano Switzerland. Those that werent able to attend can learn more below. #18ICML #lymphoma"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1945453363765584037) 2025-07-16 12:00:01 UTC 1254 followers, XX engagements "Staging guidelines for hepatocellular carcinoma (HCC) alone may not tell the whole story of a patients experience. Watch Krittiya Korphaisarn MD explain this topic in the video below"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1944003810101539212) 2025-07-12 12:00:00 UTC 1254 followers, 72.8K engagements "Biomarkers including circulating tumor DNA (ctDNA) and immune profiling along with antibody-drug conjugates (ADCs) are enhancing the personalization of cancer treatment contributing to the development of precision #oncology. #Biomarkers"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1935683996437901365) 2025-06-19 13:00:02 UTC 1254 followers, XXX engagements "What are some of the risk factors for hepatocellular carcinoma (HCC) Learn more from Krittiya Korphaisarn MD in the video below"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1943701818799804458) 2025-07-11 16:00:00 UTC 1254 followers, 83.3K engagements "We are looking forward to attending the Australian and New Zealand Urogenital and Prostate Cancer Trials Group - Annual Scientific Meeting (ANZUP) 2025 in Sydney Australia where well be presenting research. #ANZUP25 #KidneyCancer"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1946178140880921005) 2025-07-18 12:00:01 UTC 1255 followers, XX engagements "Our team recently attended the British Thyroid Association Annual Meeting where we presented new research on radioiodine-refractory differentiated thyroid cancer (RAI-R DTC). #thycsm"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1947627699247452220) 2025-07-22 12:00:03 UTC 1254 followers, XX engagements "Its important to understand the nuances of adverse event (AE) monitoring when it comes to tyrosine kinase inhibitors (TKIs). Clinicians patients and caregivers should all stay vigilant and report any issues in a timely manner. Here are some helpful tips"  [@EisaiGlobalOnc](/creator/x/EisaiGlobalOnc) on [X](/post/tweet/1935008299453133073) 2025-06-17 16:15:03 UTC 1254 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@EisaiGlobalOnc Eisai Oncology Medical
Eisai Oncology Medical posts on X about $4523t, japan, amsterdam, drugs the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXXX +11%
- X Month XXXXXXX +453%
- X Months XXXXXXX +53%
- X Year XXXXXXX -XX%
Mentions: XX #
- X Month XX -XX%
- X Months XX +1,000%
- X Year XX +740%
Followers: XXXXX #
- X Week XXXXX +1.10%
- X Month XXXXX +2.10%
- X Months XXXXX +8.50%
- X Year XXXXX +19%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence countries XX% travel destinations XXXX%
Social topic influence $4523t 100%, japan 12.5%, amsterdam 6.25%, drugs 6.25%, switzerland 6.25%, australia 6.25%, sydney 6.25%, new zealand 6.25%, dtc XXXX%
Top accounts mentioned or mentioned by @jgong15 @maychomd @icmlugano
Top Social Posts #
Top posts by engagements in the last XX hours
"Theres been debate that patients with hepatitis B virus and cirrhosis may have a chance for early detection of hepatocellular carcinoma (HCC). Hear doctors @jgong15 and @MayCho_MD discuss the possible link between hepatitis and #livercancer"
@EisaiGlobalOnc on X 2025-06-24 16:15:04 UTC 1254 followers, 36.9K engagements
"Join us from July 17-19 at the joint 67th Annual Meeting of the Japan Society of Gynecologic Oncology and Asian Society of Gynecologic Oncology 2025 congress. Well be there sharing the latest research in endometrial cancer. #ASGO2025 #JSGO2025" @EisaiGlobalOnc on X 2025-07-16 12:30:00 UTC 1254 followers, XXX engagements
"Deregulation of complex signaling pathways may contribute to cancer which has led to research and studies of targeted cancer therapies" @EisaiGlobalOnc on X 2025-06-26 16:15:05 UTC 1254 followers, XXX engagements
"Our team recently attended the Annual Meeting of the Japanese Association of Supportive Care in Cancer. We were honored to meet with many attendees and to share research. #JASCC2025 #gynsm" @EisaiGlobalOnc on X 2025-07-15 12:00:00 UTC 1254 followers, XX engagements
"What factors guide treatment decisions for unresectable non-metastatic hepatocellular carcinoma (HCC) Krittiya Korphaisarn MD explains more" @EisaiGlobalOnc on X 2025-07-14 12:00:01 UTC 1254 followers, 1067 engagements
"Join us from July 17-19 at the joint 67th Annual Meeting of the Japan Society of Gynecologic Oncology and Asian Society of Gynecologic Oncology 2025 congress. Well be there sharing the latest research in endometrial cancer. #ASGO2025 #JSGO2025" @EisaiGlobalOnc on X 2025-07-19 02:00:01 UTC 1255 followers, XXX engagements
"Our team shared new research at the International Kidney Cancer Symposium in Amsterdam. #oncology #IKCSEU25 #kcsm" @EisaiGlobalOnc on X 2025-07-21 12:00:02 UTC 1255 followers, XX engagements
"The potential use of monoclonal antibodies (mAbs) to precisely target tumors changed the shape of #cancerresearch in the mid-1970s. In 2000 antibody-drug conjugates (ADCs) built from that strength and added to a new approach in cancer treatment. #cancertechnology" @EisaiGlobalOnc on X 2025-07-17 12:00:03 UTC 1254 followers, XX engagements
"Enrollment is now open for our randomized dose optimization study of E7386 in combination with other anticancer drug(s) in patients with endometrial carcinoma. #oncology #EC" @EisaiGlobalOnc on X 2025-07-10 14:43:17 UTC 1254 followers, XXX engagements
"We were proud to have been able to share new research on follicular lymphoma at the 18th International Conference on Malignant Lymphoma (@ICMLugano) in Lugano Switzerland. Those that werent able to attend can learn more below. #18ICML #lymphoma" @EisaiGlobalOnc on X 2025-07-16 12:00:01 UTC 1254 followers, XX engagements
"Staging guidelines for hepatocellular carcinoma (HCC) alone may not tell the whole story of a patients experience. Watch Krittiya Korphaisarn MD explain this topic in the video below" @EisaiGlobalOnc on X 2025-07-12 12:00:00 UTC 1254 followers, 72.8K engagements
"Biomarkers including circulating tumor DNA (ctDNA) and immune profiling along with antibody-drug conjugates (ADCs) are enhancing the personalization of cancer treatment contributing to the development of precision #oncology. #Biomarkers" @EisaiGlobalOnc on X 2025-06-19 13:00:02 UTC 1254 followers, XXX engagements
"What are some of the risk factors for hepatocellular carcinoma (HCC) Learn more from Krittiya Korphaisarn MD in the video below" @EisaiGlobalOnc on X 2025-07-11 16:00:00 UTC 1254 followers, 83.3K engagements
"We are looking forward to attending the Australian and New Zealand Urogenital and Prostate Cancer Trials Group - Annual Scientific Meeting (ANZUP) 2025 in Sydney Australia where well be presenting research. #ANZUP25 #KidneyCancer" @EisaiGlobalOnc on X 2025-07-18 12:00:01 UTC 1255 followers, XX engagements
"Our team recently attended the British Thyroid Association Annual Meeting where we presented new research on radioiodine-refractory differentiated thyroid cancer (RAI-R DTC). #thycsm" @EisaiGlobalOnc on X 2025-07-22 12:00:03 UTC 1254 followers, XX engagements
"Its important to understand the nuances of adverse event (AE) monitoring when it comes to tyrosine kinase inhibitors (TKIs). Clinicians patients and caregivers should all stay vigilant and report any issues in a timely manner. Here are some helpful tips" @EisaiGlobalOnc on X 2025-06-17 16:15:03 UTC 1254 followers, XXX engagements